Abstract:Preclinical efficacy and toxicity assessment of drug candidates plays a significant role in drug discovery and development. Traditional planar cell culture is a common way to perform the preclinical drug test, but it is difficult to correctly predict the drug efficacy and toxicity due to the simple two-dimensional (2D) extracellular microenvironment. Compared to the planar cell culture, three-dimensional (3D) cell culture system can better mimic the complex extracellular microenvironment where cells reside in the 3D tissues/organs in vivo. However, the conventional imaging techniques are difficult to achieve the dynamic and label-free monitoring of cellular behavior in thick sample by 3D cell culture. Here, 3D electric cell/matrigel-substrate impedance sensing (3D-ECMIS) is developed for real-time and non-invasive monitoring of 3D cell viability and drug susceptibility. In this study, human hepatoma cells (HepG2) are encapsulated in the matrigel scaffold and cultured in a 3D ECMIS chip which involves a pair of vertical golden electrodes on the opposite sidewalls of the culture chamber for the in-situ impedance measurement. Moreover, a portable multichannel system is developed to monitor the 3D cell/matrigel construct. The number of 3D-cultured cells was inversely proportional to the impedance magnitude of the entire cell/matrigel construct. Furthermore, anti-cancer drug screening will be conducted on the 3D-cultured cells when the cell proliferation reaches to a plateau phase. To validate the performance of 3D-ECMIS for the cell viability and drug susceptibility, the cell live/dead staining are utilized to confirm the results of drug susceptibility by this 3D-cell-based biosensor system. It is demonstrated that the 3D cell-based biosensor and 3D-ECMIS system will be a promising platform to improve the accuracy of cell-based anti-cancer drug screening in vitro.

Electrochemical Trans-Channel Assay for Efficient Evaluation of Tumor Cell Invasiveness

In Situ Continuously Monitoring of Cancer Cell Invasion Process Based on Impedance Sensing

3D Cell-Based Biosensor for Cell Viability and Drug Assessment by 3D Electric Cell/matrigel-Substrate Impedance Sensing.

3D Microgroove Electrical Impedance Sensing to Examine 3D Cell Cultures for Antineoplastic Drug Assessment

Micro-electrode cell-based biosensor using electrochemical impedance spectroscopy for cancer research

Real-time label-free three-dimensional invasion assay for anti-metastatic drug screening using impedance sensing

Fabrication of Channeled and Three-Dimensional Electrodes for the Integrated Capture and Detection of Invasive Circulating Tumor Cells During Hematogenous Metastasis.

Electrical Impedance Tomography for Real-Time and Label-Free Cellular Viability Assays of 3D Tumour Spheroids

Emerging Tumor-on-Chips with Electrochemical Biosensors

Electrochemical Evaluation of Tumor Development via Cellular Interface Supported CRISPR/Cas Trans-Cleavage

A review of innovative electrochemical strategies for bioactive molecule detection and cell imaging: Current advances and challenges

Impedance studies of bio-behavior and chemosensitivity of cancer cells by micro-electrode arrays

Mechanical Characterization of Cancer Cells During TGF-β1-induced Epithelial-Mesenchymal Transition Using an Electrodeformation-Based Microchip

An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1

High‐Throughput Electromechanical Coupling Chip Systems for Real‐Time 3D Invasion/Migration Assay of Cells

Micro/nanofluidic-electrochemical biosensors for in situ tumor cell analysis

Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor

Electrochemical Immunoassay on Expression of Integrin Β1 on Tumor Cells and Drug-Resistant Tumor Cells.

Electrochemical Analysis of Tumor Marker Proteins

An Automatic and Quantitative On-Chip Cell Migration Assay Using Self-Assembled Monolayers Combined with Real-Time Cellular Impedance Sensing.

Label-Free Selection of Cancer Cells by Dielectrophoresis and Evaluation of Invasive Potential by Single-Cell Protease Secretion Assay